Do you use Transcranial Magnetic stimulation (rTMS) for stroke, Parkinson’s or TBI?


A course of low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered over the supplementary motor area (SMA) improves motor symptoms in patients with Parkinson’s disease (PD), shows results from a randomized controlled trial. We may use this technique to help patients with tremor.

The rationale of using rTMS as a complementary therapy is mainly to decrease the cortical excitability in regions that are presumed to hinder optimal recovery by low-frequency rTMS delivered to the unaffected hemisphere, while high-frequency rTMS delivered to the affected hemisphere facilitates cortical excitability. However, the exact mechanisms of how rTMS works are still under investigation.

In some cases we may use this technology.

We have collaborated in a study done at MUHC with Dr Kolivakis and Dr Ptito as investigators To assess the effects of rTMS over the left Dorsolateral prefrontal cortex (DLPFC) on mood and cognitive symptoms in patients with Minor Brain Injury (mTBI) and Post Concussion Syndromes (PCS) and patients with Major Depressive Disorders (MDD) without TBI.
Results have been very encouraging in symptoms reduction such as Head aches, cognitive functions and mood regulation.

We use this technology for this condition when indicated.